Discovery of Antiseizure Compounds in Zebrafish Models for the Treatment of Drug-Resistant Epilepsy KU Leuven
With 70 million people affected worldwide is epilepsy one of the most common neurological diseases characterized by unpredictable, unprovoked, recurrent seizures. Moreover, the disease is often accompanied by psychiatric and cognitive comorbidities, affecting dramatically the quality of life of patients. So far, pharmacological intervention is the first-line treatment for epilepsy. Unfortunately, about 30% of patients experience seizures that ...